GSA Capital Partners’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
+69,799
| New | +$1.55M | 0.11% | 218 |
|
|
2024
Q4 | – | Sell |
-17,140
| Closed | -$574K | – | 1579 |
|
|
2024
Q3 | $574K | Buy |
+17,140
| New | +$574K | 0.04% | 824 |
|
|
2023
Q3 | – | Sell |
-18,721
| Closed | -$381K | – | 1470 |
|
|
2023
Q2 | $381K | Buy |
+18,721
| New | +$381K | 0.04% | 906 |
|
|
2021
Q4 | – | Sell |
-14,583
| Closed | -$395K | – | 1391 |
|
|
2021
Q3 | $395K | Buy |
+14,583
| New | +$395K | 0.04% | 842 |
|
|
2021
Q1 | – | Sell |
-13,664
| Closed | -$294K | – | 1077 |
|
|
2020
Q4 | $294K | Sell |
13,664
-12,270
| -47% | -$264K | 0.05% | 747 |
|
|
2020
Q3 | $383K | Buy |
+25,934
| New | +$383K | 0.06% | 571 |
|
|
2020
Q2 | – | Sell |
-12,178
| Closed | -$172K | – | 605 |
|
|
2020
Q1 | $172K | Sell |
12,178
-35,934
| -75% | -$508K | 0.04% | 798 |
|
|
2019
Q4 | $782K | Buy |
48,112
+35,078
| +269% | +$570K | 0.09% | 347 |
|
|
2019
Q3 | $456K | Buy |
+13,034
| New | +$456K | 0.06% | 611 |
|